Singapore markets open in 47 minutes
  • Straits Times Index

    3,138.81
    -0.16 (-0.01%)
     
  • S&P 500

    4,401.46
    -20.84 (-0.47%)
     
  • Dow

    35,058.52
    -85.79 (-0.24%)
     
  • Nasdaq

    14,660.58
    -180.14 (-1.21%)
     
  • BTC-USD

    39,200.47
    +1,846.38 (+4.94%)
     
  • CMC Crypto 200

    921.05
    +44.82 (+5.11%)
     
  • FTSE 100

    6,996.08
    -29.35 (-0.42%)
     
  • Gold

    1,799.90
    +0.10 (+0.01%)
     
  • Crude Oil

    71.94
    +0.29 (+0.40%)
     
  • 10-Yr Bond

    1.2340
    -0.0420 (-3.29%)
     
  • Nikkei

    27,970.22
    0.00 (0.00%)
     
  • Hang Seng

    25,086.43
    -1,105.89 (-4.22%)
     
  • FTSE Bursa Malaysia

    1,514.60
    +2.07 (+0.14%)
     
  • Jakarta Composite Index

    6,097.05
    -9.35 (-0.15%)
     
  • PSE Index

    6,522.58
    +149.97 (+2.35%)
     

Open Orphan starts trials on nasal spray COVID-19 vaccines

Yahoo Finance’s Anjalee Khemlani speaks with Open Orphan Executive Chairman Cathal Friel about the company’s effort to create “quarantine facilities”, and its nasal vaccine trials.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting